Results for tag: "Urinary Antibacterials"

The Urinary Antibacterials market is a subset of the Antibiotics market, which is composed of drugs used to treat bacterial infections. Urinary Antibacterials are used to treat infections of the urinary tract, such as cystitis, urethritis, and pyelonephritis. These drugs are typically administered orally or intravenously, and may be used in combination with other antibiotics. Commonly used Urinary Antibacterials include cephalosporins, fluoroquinolones, and nitrofurantoin. Urinary Antibacterials are used to treat a wide range of bacterial infections, and are often prescribed as a first-line treatment. They are generally well-tolerated and have few side effects. However, they may cause allergic reactions in some patients, and should be used with caution in those with a history of allergies. Some companies in the Urinary Antibacterials market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi. Show Less Read more